• Slide3 image Description
  • Image Description
  • Slide2
  • Description
  • Description
  • Description

News

  • 1
  • 2
  • 3

Italian ceramic “pole” acquires Elios, I…

04-08-2017

MCP II goes on with acquisitions, aiming EUR 300 million turnover “Italian ...

MCP II announces acquisition of La Fabbr…

28-04-2017

The Italian investment fund Mandarin Capital Partners II - MCP II, along wi...

MCP II acquires Mipharm Spa

06-12-2016

The goal is to support the international growth of the Company, leveraging ...

MCP II invests in Marval Group

10-03-2016

The goal is to support the international growth of the Group through Mandar...

Final close of MCP II

29-12-2015

Mandarin Capital Partners, the private equity firm that specializes in inve...

Zoomlion grows in Italy, control Ladurne…

21-12-2015

21 dec, 2015 _ The Chinese  giant of construction machinery, Zoomlion, stre...

Dove e come investiamo

Mandarin Capital Partners investe in aziende italiane e cinesi di medie dimensioni, prevalentemente non quotate, con prospettive di incremento della redditività attraverso l’attuazione di progetti di internazionalizzazione rispettivamente in Cina e in Europa.

Leggi tutto ...

Promotori

L’idea del Fondo Mandarin nasce dall’incontro tra Alberto Forchielli, profondo conoscitore dei mercati asiatici e fondatore di Osservatorio Asia, e il team di private equity guidato da Enrico Ricotta, forte di un pluriennale track-record presso primarie realtà internazionali (IMI ABN AMRO, Dresdner Kleinwort Capital).

Mission

Mandarin Capital Partners è un fondo di Private Equity che crea collegamenti tra medie aziende europee e partner commerciali ed industriali cinesi. Il fondo supporta le aziende in portafoglio nei processi di crescita, internazionalizzazione e razionalizzazione. Il team europeo (con base a Milano e Francoforte) e cinese (Shanghai) lavorano in modo integrato al fine di apportare valore alle aziende in portafoglio. A dicembre 2015 Mandarin Capital Partners ha completato con successo la raccolta del secondo fondo, con capitali raccolti pari circa a €200 milioni.

Leggi tutto ...

Team

Map

Mandarin Capital Partners è gestito da un team internazionale di professionisti con basi in Lussemburgo, a Milano, Lugano, Hong Kong, Shanghai e Pechino.
Leggi tutto ...

MCP II acquires Mipharm Spa

The goal is to support the international growth of the Company, leveraging Mipharm as a growth platform in the CDMO industry
Milan, 06th December 2016 - Mandarin Capital Partners II (MCP II)  has successfully acquired a majority stake in the share capital of Mipharm Spa, an Italian leading Contract Manufacturing Organization (“CMO”) engaged in the manufacturing and packaging of a wide range of Finished Dosage Formulations (“FDFs”). The Group also provides product development services and clinical studies based on customer requirements and/or in house R&D.
MCP II total initial investment amounts to € 16.4 million, with the goal to increase the total investment with acquisitions of selected targets. Cassiopea Partners (Buyer’s financial advisor), Euteam (company owned by Mr. Maurizio Silvestri - ex CEO of Euticals) and some of Mipharm’s Managers invested alongside MCP II.
Current CEO Mr. Pierangelo Costa will continue to manage the company. Mipharm has posted sales of around € 37.9 m in 2015, with approx. 45 clients (Big Pharma, Global Generic companies, other pharmaceutical companies) located in 30 countries (i.e. in 2015 Exports account for about 65% of Revenues).
The investment is aimed at supporting international growth of the Company, leveraging on MCP II’s network and business development channels in the European and Asian markets.
Cassiopea Partners and the lawyersof R&P Legal of Milan acted respectively as financial and legal advisor for MCP II; Banca Popolare di Milano (BPM) and Banca Popolare Emilia Romagna (BPER) acted as financing banks providing the acquisition and M&A lines. The seller was supported by Rothschild as financial advisor and by the lawyersof Bonelli Erede Pappalardo as legal advisor.
The due diligence process was conducted by Ernst & Young (financial and tax areas), R&P Legal (legal area), Goetz Partners (business) and Tauw (Environmental).
Mandarin CP